A new trading day began on August 04, 2022, with Alzamend Neuro Inc. (NASDAQ: ALZN) stock priced at $0.9089, up 10.38% from the previous day of trading. During the day, the shares moved up to $1.10 and dropped to $0.9089 before settling in for the closing price of $0.92. ALZN’s price has ranged from $0.80 to $4.54 over the past 52 weeks.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
Sponsored
Meanwhile, its annual earnings per share averaged -133.50%. With a float of $47.25 million, this company’s outstanding shares have now reached $87.93 million.
The firm has a total of 4 workers. Let’s measure their productivity.
Alzamend Neuro Inc. (ALZN) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alzamend Neuro Inc. is 3.50%, while institutional ownership is 3.50%. The most recent insider transaction that took place on Aug 03, was worth 1,896. In this transaction 10% Owner of this company bought 2,000 shares at a rate of $0.95, taking the stock ownership to the 9,936,667 shares. Before that another transaction happened on Jul 27, when Company’s 10% Owner bought 5,700 for $0.87, making the entire transaction worth $4,959. This insider now owns 9,934,667 shares in total.
Alzamend Neuro Inc. (ALZN) Earnings and Forecasts
In its latest quarterly report, released on 4/29/2022, the company reported earnings of -$0.04 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). This company achieved a return on equity of -160.92. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -133.50% per share during the next fiscal year.
Alzamend Neuro Inc. (NASDAQ: ALZN) Trading Performance Indicators
Here are Alzamend Neuro Inc.’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 12.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit -0.06 in the next quarter
Technical Analysis of Alzamend Neuro Inc. (ALZN)
Analysing the last 5-days average volume posted by the [Alzamend Neuro Inc., ALZN], we can find that recorded value of 0.47 million was lower than the volume posted last year of 1.07 million. As of the previous 9 days, the stock’s Stochastic %D was 53.82%. Additionally, its Average True Range was 0.06.
During the past 100 days, Alzamend Neuro Inc.’s (ALZN) raw stochastic average was set at 32.26%, which indicates a significant decrease from 63.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.27% in the past 14 days, which was lower than the 68.54% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9170, while its 200-day Moving Average is $1.4195. Now, the first resistance to watch is $1.1037. This is followed by the second major resistance level at $1.1974. The third major resistance level sits at $1.2948. If the price goes on to break the first support level at $0.9126, it is likely to go to the next support level at $0.8152. Should the price break the second support level, the third support level stands at $0.7215.
Alzamend Neuro Inc. (NASDAQ: ALZN) Key Stats
With a market capitalization of 94.98 million, the company has a total of 95,482K Shares Outstanding. Currently, annual sales are 0 K while annual income is -12,360 K. The company’s previous quarter sales were 0 K while its latest quarter income was -3,870 K.
